Rapid Micro Biosystems (NASDAQ:RPID) Research Coverage Started at KeyCorp

KeyCorp initiated coverage on shares of Rapid Micro Biosystems (NASDAQ:RPID) in a report released on Wednesday morning, Marketbeat reports. The firm issued an overweight rating and a $8.00 price objective on the stock. KeyCorp also issued estimates for Rapid Micro Biosystems’ FY2024 earnings at ($1.10) EPS, Q1 2025 earnings at ($0.27) EPS, Q2 2025 earnings at ($0.25) EPS, Q3 2025 earnings at ($0.24) EPS, Q4 2025 earnings at ($0.23) EPS, FY2025 earnings at ($0.97) EPS and FY2026 earnings at ($0.82) EPS.

Rapid Micro Biosystems Trading Down 2.5 %

Shares of RPID opened at $3.48 on Wednesday. Rapid Micro Biosystems has a twelve month low of $0.58 and a twelve month high of $3.75. The firm’s fifty day simple moving average is $1.50 and its 200-day simple moving average is $1.13. The firm has a market capitalization of $149.74 million, a price-to-earnings ratio of -3.11 and a beta of 1.26.

Institutional Investors Weigh In On Rapid Micro Biosystems

An institutional investor recently raised its position in Rapid Micro Biosystems stock. Renaissance Technologies LLC increased its stake in shares of Rapid Micro Biosystems, Inc. (NASDAQ:RPID) by 122.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 183,087 shares of the company’s stock after acquiring an additional 100,942 shares during the quarter. Renaissance Technologies LLC owned about 0.43% of Rapid Micro Biosystems worth $165,000 at the end of the most recent quarter. Institutional investors own 52.60% of the company’s stock.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.